NCT01665508View on ClinicalTrials.gov

Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Microvascular Angina

Interventions

DRUG

Nebivolol

Patient to start nebivolol and have repeat testing in 3 months

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Massachusetts General Hospital

OTHER